BRCA1 Promoter Methylation and Expression - Associations with ER+, PR+ and HER2+ Subtypes of Breast Carcinoma
Conclusion: Reduced expression was associated with ER and PR
negative status which is linked with a poor prognosis. BRCA1 protein expression might thus be used as a prognostic
indicator to predict treatment response to hormone therapy.
PMID: 29286222 [PubMed - as supplied by publisher]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Genetics | HER2 | Hormonal Therapy | Hormones | Statistics | Study